Curran Daniel J.
SEC insider (Form 3/4/5 filer). CIK 0001887599. Director at CATALYST PHARMACEUTICALS, INC. (CPRX) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CORAL GABLES, FL.
Companies Curran Daniel J. has filed insider reports for
- CATALYST PHARMACEUTICALS, INC. (CPRX): Director
- Xilio Therapeutics, Inc. (XLO): Director
- ALX ONCOLOGY HOLDINGS INC (ALXO): Director
Curran Daniel J.
CIK: 0001887599
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 15, 2026CPRX
CATALYST PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Units
5.5K shares- - Jul 15, 2026CPRX
CATALYST PHARMACEUTICALS, INC.
DispositionDirectOptions to purchase common stock
18.1K shares- - Jul 15, 2026CPRX
CATALYST PHARMACEUTICALS, INC.
DispositionDirectOptions to purchase common stock
40K shares- - Jun 11, 2026XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares- - Jan 20, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock Option (right to buy)
16.8K shares- - Nov 20, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
5.5K shares- - Nov 20, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectOptions to purchase common stock
18.1K shares- - Aug 12, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
40.4K shares- - Jun 11, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
31K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  CPRX CATALYST PHARMACEUTICALS, INC. | Disposition Restricted Stock Units | 5,468 | - | - | Direct |
| Jul 15, 2026 | CPRX CATALYST PHARMACEUTICALS, INC. | Disposition Options to purchase common stock | 18,115 | - | - | Direct |
| Jul 15, 2026 | CPRX CATALYST PHARMACEUTICALS, INC. | Disposition Options to purchase common stock | 40,000 | - | - | Direct |
| Jun 11, 2026 |  XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 5,000 | - | - | Direct |
| Jan 20, 2026 |  ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock Option (right to buy) | 16,833 | - | - | Direct |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Restricted Stock Units | 5,468 | - | - | Direct |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Options to purchase common stock | 18,115 | - | - | Direct |
| Aug 12, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 40,400 | - | - | Direct |
| Jun 11, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 31,000 | - | - | Direct |
1-9 of 9 transactions